A
15.62
-0.11 (-0.70%)
| Penutupan Terdahulu | 15.73 |
| Jumlah Dagangan | 3,643,985 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.75 |
| Harga / Jualan (P/S) | 1.60 |
| Harga / Buku (P/B) | 1.81 |
| Julat 52 Minggu |
| Margin Keuntungan | 10.70% |
| Margin Operasi (TTM) | 8.21% |
| EPS Cair (TTM) | 1.04 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -5.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 6.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 67.34% |
| Nisbah Semasa (MRQ) | 1.12 |
| Aliran Tunai Operasi (OCF TTM) | 808.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 751.08 M |
| Pulangan Atas Aset (ROA TTM) | 3.53% |
| Pulangan Atas Ekuiti (ROE TTM) | 12.52% |
AISkor Stockmoo
| Nilai 30% | -2.8 |
| AI Insight info | NA |
| Penilaian Relatif info | -5.0 |
| Kesihatan Kewangan info | 0.6 |
| Masa 30% | 1.1 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | 3.5 |
| Sentimen 20% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Sentimen Berita info | NA |
| Wang Pintar 20% | 1.5 |
| Aktiviti Orang Dalam info | 1.5 |
| Aliran Institusi info | NA |
| Persekitaran | ×1.10 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | +6.8% |
| Persetujuan Tonggak | ×0.82 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -5.0 |
| Skor Akhir | -0.18 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Avantor, Inc. | Bercampur | Menurun |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| AVTR | - | - | - | 1.81 |
| TFX | - | 0.98% | - | 1.83 |
| BAX | - | 0.73% | - | 2.11 |
| ALC | - | 0.49% | - | 1.59 |
| STVN | - | 0.30% | - | 2.04 |
| BDX | - | 2.20% | - | 2.37 |
|
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.35% |
| % Dimiliki oleh Institusi | 103.17% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| New Mountain Capital, L.L.C. | 30 Sep 2026 | 14,000,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Nov 2026 | Yahoo Finance |
Avantor: 3 Key Takeaways for Long-Term Investors
Factory output gains and debt paydown signal the company is converting growth into financial flexibility. |
| 03 Nov 2026 | Yahoo Finance |
3 unpopular stocks with open questions
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory. |
| 02 Nov 2026 | Yahoo Finance |
Cell and Tissue Culture Supplies - Global Strategic Business Report: Capitalize on the US$97.7 Billion Surge as Avantor, Corning, Lonza, and Thermo Fischer Scientific Reshape Competition
Boost ROI through automation, 3D culture and specialty media that enhance throughput, reproducibility and drug-screening accuracy while reducing manual work and animal testing.Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Cell and Tissue Culture Supplies - Global Strategic Business Report" has been… |
| 30 Oct 2026 | Yahoo Finance |
Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?
Avantor (AVTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
| 30 Oct 2026 | Yahoo Finance |
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and Novartis (NVS) have performed compared to their sector so far this year. |
| 30 Oct 2026 | Yahoo Finance |
Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?
Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out. |
| 30 Oct 2026 | Yahoo Finance |
Avantor (AVTR) Stock Drops As Q3 Earnings Rebound Meets Caution
Avantor came into this Q3 2026 report with its stock quietly rebuilding credibility, up over the past quarter and priced near the middle of its recent range. The headline this time is clear. The lab supplies group reported US$1.698b of revenue and basic earnings per share of about US$0.30, while… |
| 29 Oct 2026 | Yahoo Finance |
Repligen Soars 5% as RBC Raises Price Target to $200 After Full-Year Guidance Hike
Key TakeawaysRepligen shares rose 5% after RBC Capital raised its price target to $200, a day after the company beat estimates and raised its full-year revenue outlook. Repligen’s 12… |
| 28 Oct 2026 | Yahoo Finance |
Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates
Avantor (AVTR) delivered earnings and revenue surprises of +4.76% and +3.53%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 28 Oct 2026 | Yahoo Finance |
Avantor, Inc. Q3 2026 Earnings Call Summary
Moby summary of Avantor, Inc.'s Q3 2026 earnings call… |
| 28 Oct 2026 | Yahoo Finance |
Avantor (NYSE:AVTR) reports upbeat Q3 2026
Life sciences company Avantor (NYSE:AVTR) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 4.6% year on year to $1.70 billion. Its non-GAAP profit of $0.22 per share was 5.6% above analysts’ consensus estimates. |
| 28 Oct 2026 | Yahoo Finance |
What Avantor (AVTR) Said on Its Q3 Earnings Call
Avantor (NYSE:AVTR) reported a return to organic revenue growth in the third quarter of 2026, led by accelerating performance in its VWR Distribution & Services segment and a return to growth in its Bioscience & Medtech Products business. Revenue totaled $1.698 billion, up 5.2% organically… |
| 28 Oct 2026 | Yahoo Finance |
Avantor® Reports Third Quarter 2026 Results
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports results that exceeded management's expectations for revenue and adjusted EPS for the third fiscal quarter of 2026… |
| 28 Oct 2026 | Yahoo Finance |
Avantor (AVTR) Q3 2026 Earnings Call Transcript
Ligner discusses return to organic growth and Revival program progress. |
| 27 Oct 2026 | Yahoo Finance |
What to expect from Avantor’s (AVTR) Q3 earnings
Life sciences company Avantor (NYSE:AVTR) will be reporting results this Wednesday before market open. Here’s what investors should know. |
| 26 Oct 2026 | Yahoo Finance |
Avantor appoints new Chief Information Officer
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes Mikey Santiago as its new Chief Information Officer. |
| 23 Oct 2026 | Yahoo Finance |
How Organic Growth Recovery Will Impact Avantor Stock Investors
Avantor reported a more than 50% share price gain in Q3 2026 after organic growth returned in its VWR distribution business and order activity in Bioprocessing improved under CEO Emmanuel Ligner's turnaround plan. The renewed focus on organic growth, a recovery in VWR and Bioprocessing orders, and… |
| 21 Oct 2026 | Yahoo Finance |
Avantor (AVTR) is Regaining Market Confidence
Longleaf Partners, managed by Southeastern Asset Management, released its third-quarter 2026 investor letter for its “Partners Fund”. The letter can be downloaded here. Coming into this year, the Fund’s three-year annualized returns were at 11.7%, but recent performance, particularly this year and… |
| 14 Oct 2026 | Yahoo Finance |
Single-Use Assemblies Global Market Report 2026-2030 | Capitalize on 22.8% CAGR as Thermo Fisher, Danaher, Sartorius, Merck, and Avantor Scale Modular Bioprocessing
Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to reduce tariff and supply-chain risks.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Single-Use Assemblies Market Report 2026" has been added to… |
| Papar semua | ||
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |